Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FSU86
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,831
Award facts
- Contract value 100% obligated
- $20,830.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $20,830.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. This firm fixed-price delivery order, awarded on October 28, 2025, with an ultimate completion date of November 19, 2025, requires performance in Park Ridge, Illinois. The award carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in an unrestricted procurement environment. DMS Pharmaceutical Group is the sole awardee on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated contract SPE2DR. The underlying IDC, awarded November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period followed by three optional 30-month periods. As a regional prime vendor contractor under the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense military healthcare facilities globally. The company's established track record across multiple therapeutic categories demonstrates its capability to fulfill specialized pharmaceutical requirements for federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FSU86?
SPE2DB26FSU86 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FSU86 worth?
The government has obligated $20,831 on SPE2DB26FSU86.
Is contract SPE2DB26FSU86 an order under another contract?
Yes. SPE2DB26FSU86 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSU86 competed?
The extent of competition for SPE2DB26FSU86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award